Fischer Medical

Market Cap: Mid Cap
Industry: Chemicals
ISIN: INE771F01025
NSEID:
BSEID: 524743

INR

834.80

14.8 (1.8%)

BSENSE

Apr 11, 12:51 PM

BSE+NSE Vol: 1.62 lacs

Click here to access the older version

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Solar Industries

Sumitomo Chemi.

Godrej Industrie

Fischer Medical

Gujarat Alkalies

Gujarat Fluoroch

Neogen Chemicals

Grauer & Weil

Deepak Nitrite

India Glycols

Balaji Amines

Why is Fischer Medical Ventures Ltd ?

With a Operating Losses, the company has a Weak Long Term Fundamental Strength

Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 1.68
The company has been able to generate a Return on Equity (avg) of 2.29% signifying low profitability per unit of shareholders funds

Flat results in Dec 24

With ROE of 2.3, it has a Very Expensive valuation with a 64.9 Price to Book Value

Over the past year, while the stock has generated a return of 28.64%, its profits have fallen by 0%

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Chemicals)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Fischer Medical for you?

High Risk, High Return

Absolute

Risk Adjusted

Volatility

Fischer Medical

28.77%

0.65

44.36%

SENSEX

0.45%

0.03

14.48%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.00%

EBIT Growth (5y)

0.00%

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

6.76%

ROCE (avg)

0.06%

ROE (avg)

2.29%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

2843

Industry P/E

Price to Book Value

64.93

EV to EBIT

3111.74

EV to EBITDA

2810.61

EV to Capital Employed

68.26

EV to Sales

249.18

PEG Ratio

Dividend Yield

ROCE (Latest)

2.19%

ROE (Latest)

2.28%

Loading Valuation Snapshot...

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bullish

RSI

No Signal

Bollinger Bands

Mildly Bullish

Moving Averages

Bullish (Daily)

KST

Bullish

Mildly Bearish

Dow Theory

Mildly Bearish

Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company

PAT(9M)

At Rs 1.55 cr has Grown at 838.10%

0What is not working for the Company

NO KEY NEGATIVE TRIGGERS

Loading Valuation Snapshot...

Here's what is working for Fischer Medical

Profit After Tax (PAT) - Nine Monthly

At Rs 1.55 cr has Grown at 838.10%

Year on Year (YoY)

MOJO Watch

PAT trend is very positive

PAT (Rs Cr)

Profit After Tax (PAT) - Nine Monthly

Higher at Rs 1.55 Cr

than preceding 12 month period ended Dec 2024 of Rs 0.39 cr

MOJO Watch

In the nine month period the company has already crossed sales of the previous twelve months

PAT (Rs Cr)